[HTML][HTML] CRISPR in cancer biology and therapy

A Katti, BJ Diaz, CM Caragine, NE Sanjana… - Nature Reviews …, 2022 - nature.com
Over the past decade, CRISPR has become as much a verb as it is an acronym,
transforming biomedical research and providing entirely new approaches for dissecting all …

[HTML][HTML] Hallmarks of cancer: The CRISPR generation

C Moses, B Garcia-Bloj, AR Harvey… - European Journal of …, 2018 - Elsevier
The hallmarks of cancer were proposed as a logical framework to guide research efforts that
aim to understand the molecular mechanisms and derive treatments for this highly complex …

CRISPR–Cas: a tool for cancer research and therapeutics

H Yin, W Xue, DG Anderson - Nature Reviews Clinical Oncology, 2019 - nature.com
In the past decade, the development of a genome-editing technology mediated by CRISPR
has made genetic engineering easier than ever, both in vitro and in vivo. CRISPR systems …

[HTML][HTML] CRISPR therapeutic tools for complex genetic disorders and cancer

S Baliou, M Adamaki… - International …, 2018 - spandidos-publications.com
One of the fundamental discoveries in the field of biology is the ability to modulate the
genome and to monitor the functional outputs derived from genomic alterations. In order to …

CRISPR/Cas9 for cancer therapy: hopes and challenges

M Martinez-Lage, P Puig-Serra, P Menendez… - Biomedicines, 2018 - mdpi.com
Cancer is the second leading cause of death globally and remains a major economic and
social burden. Although our understanding of cancer at the molecular level continues to …

CRISPR–Cas13 precision transcriptome engineering in cancer

JT Granados-Riveron, G Aquino-Jarquin - Cancer research, 2018 - AACR
The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-
associated genes (Cas) system has been rapidly harnessed to perform various genomic …

[HTML][HTML] CRISPR/Cas: advances, limitations, and applications for precision cancer research

Y Yang, J Xu, S Ge, L Lai - Frontiers in medicine, 2021 - frontiersin.org
Cancer is one of the most leading causes of mortalities worldwide. It is caused by the
accumulation of genetic and epigenetic alterations in 2 types of genes: tumor suppressor …

[HTML][HTML] CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer

SC Selvakumar, KA Preethi, K Ross, D Tusubira… - Molecular Cancer, 2022 - Springer
Background Cancer is caused by a combination of genetic and epigenetic abnormalities.
Current cancer therapies are limited due to the complexity of their mechanism, underlining …

Applications of CRISPR-Cas enzymes in cancer therapeutics and detection

CH Huang, KC Lee, JA Doudna - Trends in cancer, 2018 - cell.com
Cancer is a complex disease caused by combinations of cellular genetic alterations and
heterogeneous microenvironments. The use of the robust and programmable CRISPR-Cas …

[HTML][HTML] CRISPR/Cas9–An evolving biological tool kit for cancer biology and oncology

X Tian, T Gu, S Patel, AM Bode, MH Lee… - NPJ precision …, 2019 - nature.com
The development of genetic engineering in the 1970s marked a new frontier in genome-
editing technology. Gene-editing technologies have provided a plethora of benefits to the life …